Emily L Pfentner is a Amherst, New York based nurse practitioner. Active license number of Emily L Pfentner is F341925-1 for Family in New York. Her current practice location is 3980 Sheridan Dr, Amherst. Patients can reach her at 716-250-2000. Emily L Pfentner is FNP and her NPI number (Unique professional ID assigned by NPPES) is 1790128890. Emily L Pfentner has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Emily L Pfentner speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790128890
NPI Enumeration Date:
09 Apr, 2013
NPI Last Update On:
21 Jul, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily L Pfentner are as mentioned below.
License Number
Specialization
State
Status
F341925-1
Family
New York
Primary
660623
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Emily L Pfentner 3980 Sheridan Dr, Amherst, New York
Zip:
14226-1727
Phone Number:
716-250-2000
Patients can reach Emily L Pfentner at 3980 Sheridan Dr, Amherst, New York or can call to book an appointment on 716-250-2000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.